Medical Journal of Indonesia
https://mji.ui.ac.id/journal/index.php/mji
<p><a href="http://mji.ui.ac.id/journal/index.php/mji/aboutbrief">ABOUT JOURNAL</a> | <a href="http://scholar.google.com/citations?user=4rXbpKoAAAAJ&hl=en" target="_blank"">CITATIONS</a> | <a href="https://mji.ui.ac.id/journal/index.php/mji/stat">STATISTIC</a> | <a href="/journal/index.php/mji/submit">SUBMISSIONS</a> | <a href="/journal/index.php/mji/indexing">ABSTRACTING & INDEXING</a></p> <hr> <p>This quarterly medical journal is an official scientific journal of the Faculty of Medicine Universitas Indonesia in collaboration with German-Indonesian Medical Association (DIGM).</p> <p>Abstracted and indexed in: <a title="EBSCO host" href="https://www.ebscohost.com/titleLists/a9h-journals.htm" target="_blank" rel="noopener">EBSCO host</a>, <a title="ACI" href="http://www.asean-cites.org/index.php?r=contents%2Findex&id=9" target="_blank" rel="noopener">ASEAN Citation Index</a>, <a title="BASE" href="https://www.base-search.net/Search/Results?lookfor=dccoll%3Aftdoaj*+mji.ui.ac.id&refid=dclink" target="_blank" rel="noopener">BASE</a>, <a title="CABI" href="http://www.cabi.org/publishing-products/online-information-resources/cab-abstracts/?newtitlesonly=0&letter=M#SerialsCited" target="_blank" rel="noopener">CABI</a>, <a title="CiteFactor" href="http://www.citefactor.org/journal/index/6085/medical-journal-of-indonesia#.VCANOPmSxBF" target="_blank" rel="noopener">CiteFactor</a>, <a title="CNKI" href="http://eng.scholar.cnki.net/result.aspx?q=SOURCE%3a(Medical+Journal+of+Indonesia)&rt=Journal" target="_blank" rel="noopener">CNKI</a>, <a title="Crossref" href="http://search.crossref.org/?q=%22medical+journal+of+indonesia%22&publication=Medical+Journal+of+Indonesia" target="_blank" rel="noopener"> Crossref</a>, <a title="Dimensions" href="https://app.dimensions.ai/discover/publication?or_facet_source_title=jour.1114531" target="blank">Dimensions</a>, <a title="Electronic Journals Library" href="http://rzblx1.uni-regensburg.de/ezeit/searchres.phtml?bibid=AAAAA&colors=7&lang=en&jq_type1=KT&jq_term1=medical+journal+of+indonesia" target="_blank" rel="noopener">Electronic Journals Library</a>, <a title="Embase" href="https://www.elsevier.com/solutions/embase-biomedical-research/embase-coverage-and-content" target="_blank" rel="noopener">Embase</a>, <a title="ESCI" href="http://ip-science.thomsonreuters.com/cgi-bin/jrnlst/jlresults.cgi?PC=MASTER&Full=medical%20journal%20of%20indonesia" target="_blank" rel="noopener">ESCI</a>, <a title="GARUDA" href="http://garuda.ristekdikti.go.id/journal/view/6124" target="_self">GARUDA</a>, <a title="Google Scholar" href="http://scholar.google.co.id/scholar?q=site%3Ahttp%3A%2F%2Fmji.ui.ac.id&btnG=&hl=en&as_sdt=0%2C5" target="_blank" rel="noopener">Google Scholar</a>, <a title="Hinari" href="https://extranet.who.int/hinari/en/browse_journal_titles.php?j_init=M" target="_blank" rel="noopener">Hinari</a>, <a title="IMSEAR" href="http://imsear.li.mahidol.ac.th/handle/123456789/147053" target="_blank" rel="noopener">IMSEAR</a>, <a title="ISC" href="http://ecc.isc.gov.ir/showJournal/23140" target="_blank" rel="noopener">ISC</a>, <a title="J-Gate" href="https://jgateplus.com/home/" target="_blank" rel="noopener"> J-Gate </a>, <a title="JournalTOCs" href="http://www.journaltocs.ac.uk/index.php?action=browse&subAction=pub&publisherID=2793&journalID=29425&pageb=1&userQueryID=&sort=&local_page=1&sorType=&sorCol=1" target="_blank" rel="noopener">JournalTOCs</a>, <a title="Microsoft Academic" href="https://academic.microsoft.com/#/detail/2736615430" target="_blank" rel="noopener">Microsoft Academic</a>, <a title="MENDELEY" href="https://www.mendeley.com/profiles/medical-journal-of-indonesia/publications/" target="_blank" rel="noopener"> Mendeley</a>, <a title="PKP INDEX" href="http://index.pkp.sfu.ca/index.php/browse/index?archivesPage=29#archives">PKP index</a>, <a title="ProQuest" href="http://tls.proquest.com/tls/jsp/list/ListHTML.jsp?start=2000&productID=445&productName=ProQuest+Health+%26+Medical+Complete&IDString=445&format=formatHTML&issn=issn&prflag=prflag&cit=cit&abs=abs&pmid=pmid&combined=combined" target="_blank" rel="noopener">Proquest</a>, <a title="ROAD" href="https://portal.issn.org/resource/ISSN/2252-8083" target="_blank" rel="noopener"> ROAD</a>, <a title="Scilit" href="http://www.scilit.net/journals/23575" target="_blank" rel="noopener">Scilit</a>, <a title="Scopus" href="https://www.scopus.com/" target="_blank" rel="noopener">Scopus</a>, <a title="SINTA" href="http://sinta2.ristekdikti.go.id/journals/detail?id=663" target="_blank" rel="noopener">SINTA</a>, <a title="Ulrichsweb Global Serial Directory" href="http://ulrichsweb.serialssolutions.com/" target="_blank" rel="noopener">Ulrichsweb Global Serial Directory</a>, <a title="WorldCat" href="https://oaister.worldcat.org/search?q=pb%3AFaculty+of+Medicine+Universitas+Indonesia&fq=&dblist=239&se=%24d&sd=desc&fc=yr:_25&qt=show_more_yr%3A&cookie" target="_blank" rel="noopener">WorldCat</a>.</p> <p>Accredited journal (2020-2024) based on Ministerial Decree of the Minister of Research and Technology / Head of National Research and Innovation Agency of the Republic of Indonesia No. 148/M/KPT/2020.</p>Faculty of Medicine Universitas Indonesiaen-USMedical Journal of Indonesia0853-1773<p>Authors who publish with Medical Journal of Indonesia agree to the following terms:</p> <ol> <li class="show"><span lang="EN-GB">Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a <a title="CC BY NC" href="http://creativecommons.org/licenses/by-nc/4.0/" target="_self">Creative Commons Attribution-NonCommercial License</a> that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.</span></li> <li class="show">Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.</li> </ol>Kegel exercises with a guidebook for stress urinary incontinence treatment
https://mji.ui.ac.id/journal/index.php/mji/article/view/7142
<p><strong>BACKGROUND</strong> Stress urinary incontinence (SUI) is uncontrollable urine leakage when intra-abdominal pressure increases. Behavioral therapy with Kegel exercise is currently the best conservative management recommendation for treating SUI patients. This study aimed to investigate the success of supervised Kegel exercises using the Kegel exercises guidebook in women with SUI.</p> <p><strong>METHODS</strong> This quasi-experimental study involved both groups being taught the same regiment of Kegel exercises, but the intervention group was given the Kegel exercises guidebook. After 12 weeks, the compliance, subjective, and objective success rates were evaluated through the patient’s notes, Urinary Distress Inventory-6, Incontinence Impact Questionnaire-7, perineometer, and pad test.</p> <p><strong>RESULTS</strong> Patients with a higher level of education had lower compliance to Kegel exercises (<em>p</em> = 0.01; odds ratio [OR] 0.38; 0.18–0.79). No significant difference was observed in the subjective symptom improvement between the two groups. The intervention group had a significantly higher success rate based on objective success by analyzing the 1-hour pad test results. The intervention group was also more adherent (<em>p</em><0.001; OR 4.78; 2.51–9.0).</p> <p><strong>CONCLUSIONS</strong> Patients who received the Kegel exercises guidebook were more compliant and more objectively successful than those who did not receive the manuals.</p>Surahman HakimBudi Iman SantosoHarrina Erlianti RahardjoSiti SetiatiWidjajalaksmi KusumaningsihJoedo PrihartonoNurhadi IbrahimWresti IndriatmiErwinanto
Copyright (c) 2024 Surahman Hakim, Budi Iman Santoso, Harrina Erlianti Rahardjo, Siti Setiati, Widjajalaksmi Kusumaningsih, Joedo Prihartono, Nurhadi Ibrahim, Wresti Indriatmi, Erwinanto
2024-07-242024-07-2433280710.13181/mji.oa.247142Syndecan-4 levels in bronchoalveolar lavage fluid and serum in non-small cell lung cancer
https://mji.ui.ac.id/journal/index.php/mji/article/view/7264
<p><strong>BACKGROUND</strong> Lung cancer has the highest cancer-related mortality rate worldwide. Research has been conducted to improve early detection and markers of predictive value but only focused on the expression of syndecan-4 (SDC4) in serum. Studies in bronchoalveolar lavage (BAL) fluids of non-small cell lung cancer (NSCLC) patients are still limited. This study aimed to evaluate the clinical value of SDC4 in serum and BAL in NSCLC patients.</p> <p><strong>METHODS</strong> Blood serum and BAL fluids were obtained from 44 patients with NSCLC and 41 non-cancer patients as the control. The level of SDC4 was measured. The relationships between SDC4 and clinicopathologic factors were also analyzed.</p> <p><strong>RESULTS</strong> Serum SDC4 levels in NSCLC patients were significantly lower than the control group (<em>p</em> = 0.002). Furthermore, the disease stages and serum SDC4 levels had a negative correlation, which was lower in the advanced stage (IIIb/IV) than in the initial stage (I/II/IIIa) (<em>p</em> = 0.517). The same results were obtained from BAL fluids SDC4 levels, which were significantly lower in the advanced stage (IIIb/IV) than in the early stage (I/II/IIIa) (<em>p</em> = 0.007).</p> <p><strong>CONCLUSIONS</strong> Serum SDC4 levels in NSCLC patients were lower than those of non-cancer patients. They also performed different results in disease stages. SDC4 could be a helpful biomarker in NSCLC.</p>Asrul Abdul AzisArif SantosoIrawaty DjaharuddinHarun IskandarMuhammad IlyasNurjannah Lihawa
Copyright (c) 2024 Asrul Abdul Azis, Arif Santoso, Irawaty Djaharuddin, Harun Iskandar, Muhammad Ilyas, Nurjannah Lihawa
2024-07-242024-07-24332889210.13181/mji.oa.247264Association between immune system parameter and clinical characteristics among patients with solid cancer
https://mji.ui.ac.id/journal/index.php/mji/article/view/7272
<p><strong>BACKGROUND</strong> Lymphopenia has been reported to be a major predictor of chemotherapy-related toxicity. This study aimed to investigate the correlation between neutrophils, lymphocytes, CD4, and CD8 in solid cancer patients and cancer clinical characteristics.</p> <p><strong>METHODS</strong> This was a cross-sectional study of patients who will undergo chemotherapy at the Hematology and Medical Oncology Clinic, Cipto Mangunkusumo Hospital, from June to September 2023. Clinical characteristics, CD4 and CD8 levels, and neutrophil and lymphocyte counts were assessed at the first visit. A comparative test was carried out on the patients’ average CD4, CD8, neutrophil, and lymphocyte counts.</p> <p><strong>RESULTS</strong> Types of cancer were associated with CD4 levels. Patients with head and neck cancer had lower CD4 levels (411.3 [119.3–1,427.5] cells/mm³) compared with colorectal (514.7 [129.2–861.3] cells/mm³), breast and gynecological (567.5 [180.1–939 cells/mm³), and other cancers (681.4 [175.1–2,056.9] cells/mm³), with <em>p</em> = 0.009. Patients aged ≥40 years had higher CD8 levels than those aged <40 years (376.4 [142.8–1,293.1] cells/mm³ <em>versus</em> 565.3 [185.9–1,944] cells/mm³, <em>p</em> = 0.01). Additionally, lymphocyte count was associated with cancer type, with the lowest number in head and neck cancer (1,380 [280–2,660] μl, <em>p</em> = 0.044).</p> <p><strong>CONCLUSIONS</strong> CD4 levels and lymphocyte counts were associated with the cancer type, whereas CD8 levels were influenced by age.</p>Rahmat CahyanurAlvina WidhaniNico Iswanto PantoroAnnisa Tsana Madadika
Copyright (c) 2024 Rahmat Cahyanur, Alvina Widhani, Nico Iswanto Pantoro, Annisa Tsana Madadika
2024-07-242024-07-2433293710.13181/mji.oa.247272Transition of DNA-HPV over time in HPV-infected women: a 7-year cohort study
https://mji.ui.ac.id/journal/index.php/mji/article/view/7340
<p><strong>BACKGROUND</strong> Approximately 99% of cervical cancer cases worldwide are associated with one of the high-risk human papillomavirus (HPV) types. This study aimed to determine the transition rate of DNA-HPV over time in women aged 18–69 years with HPV infection in Can Tho City, Vietnam, from 2013 to 2020.</p> <p><strong>METHODS</strong> The 2-phase cohort study was conducted on 213 women between 2013 and 2020. Phase 1 involved a retrospective cohort study (2013–2018), and phase 2 included a prospective cohort study (2018–2020). HPV testing was performed using real-time polymerase chain reaction on cervical fluid. McNemar’s test was employed to compare differences in HPV transition between 2013 and 2020.</p> <p><strong>RESULTS</strong> From 2013 to 2018, the transition, clearance, and non-transition rates were 17.1%, 65.8%, and 66.2%, respectively, revealing a significant difference in the number of HPV cases during this period (<em>p</em> = 0.007). From 2018 to 2020, the transition, clearance, and non-transition rates were 9.8%, 44.9%, and 82.2%, respectively. Overall, the DNA-HPV changes from 2013 to 2020 indicated rates of 14.3% for transition, 68.5% for clearance, and 67.1% for non-transition. A significant difference in HPV cases was found between 2013 and 2020 (<em>p</em> = 0.001).</p> <p><strong>CONCLUSIONS</strong> The longer duration resulted in a more significant difference in the DNA-HPV transition among HPV-infected women.</p>Linh My DuongDung Ngoc TranTam Thi PhamTrang Huynh VoHung Do TranTien Thi Thuy LamDuc Long TranQuang Nghia Bui
Copyright (c) 2024 Linh My Duong, Dung Ngoc Tran, Tam Thi Pham, Trang Huynh Vo, Hung Do Tran, Tien Thi Thuy Lam, Duc Long Tran, Quang Nghia Bui
2024-07-022024-07-023329810310.13181/mji.oa.247340Diabetic foot score: a predictive model for leg amputation in patients with diabetic foot disease
https://mji.ui.ac.id/journal/index.php/mji/article/view/7427
<p><strong>BACKGROUND</strong> Patients with diabetes mellitus are at a higher risk for peripheral artery disease (PAD) and diabetic foot disease (DFD), which can ultimately result in leg amputation. This study aimed to develop a novel scoring system to predict the risk of leg amputation using widely available modalities, including demographic characteristics and various laboratory data.</p> <p><strong>METHODS</strong> This study was conducted at Dr. Soetomo General Hospital and analyzed risk factors for leg amputation in 99 patients with DFD who underwent leg amputation compared with 80 control patients. This study presented a predictive model for leg amputation in patients with DFD, using odds ratio (OR) analysis and logistic regression approach with confidence intervals (CIs) set at 95%. The data analysis was conducted using SPSS software version 25.0.</p> <p><strong>RESULTS</strong> PAD (OR 6.52, 95% CI = 2.19–19.37, <em>p</em> = 0.001), high low-density lipoprotein cholesterol (OR 5.97, 95% CI = 2.31–15.43, <em>p</em><0.001), type of DFD (OR 4.58, 95% CI = 2.14–9.79, <em>p</em><0.001), poor glycemic control (OR 4.48, 95% CI = 1.78–11.28, <em>p</em> = 0.001), and neutrophil-to-lymphocyte ratio level (OR 1.04, 95% CI = 1.00–1.07, <em>p</em> = 0.025) were the independent predictors for leg amputation. The predictive model, developed using multivariate analysis with an area under the curve of 89%, optimum threshold of 0.5 (score 6), sensitivity of 84.8%, and specificity of 78.8%, indicating a promising approach for predicting leg amputation outcomes.</p> <p><strong>CONCLUSIONS</strong> The newly developed diabetic foot score may assist in making decisions regarding therapeutic options for patients with DFD.</p>Agustinus VincentSoebagijo Adi SoelistijoDeasy ArdianyAgung PranotoMichael Austin Pradipta LusidaLukita PradheviRendra Prasetya Saefudin
Copyright (c) 2024 Agustinus Vincent, Soebagijo Adi Soelistijo, Deasy Ardiany, Agung Pranoto, Michael Austin Pradipta Lusida, Lukita Pradhevi, Rendra Prasetya Saefudin
2024-07-242024-07-243321041110.13181/mji.oa.247427Changes in body weight and healthy lifestyle perception of Indonesian adults during COVID-19 pandemic
https://mji.ui.ac.id/journal/index.php/mji/article/view/7222
<p><strong>BACKGROUND</strong> Social restrictions during the COVID-19 pandemic have impacted eating patterns and psychological status, leading to changes in body weight and perceptions of a healthy lifestyle in society. This study aimed to investigate the effect of social restrictions on weight changes and perceptions of a healthy lifestyle in adults during the COVID-19 pandemic in Indonesia.</p> <p><strong>METHODS</strong> This cross-sectional study was conducted using convenience sampling on 287 Indonesian adults from June to August 2020. The data were collected using a self-administered online questionnaire using Google Forms. Data were analyzed using the chi-square test and logistic regression analysis.</p> <p><strong>RESULTS</strong> There was no effect of social restrictions on weight changes and perceptions of lifestyle in adults (p = 0.900 and 0.748, respectively). However, 112 respondents (78.3%) had positive perceptions or supported adopting a healthy lifestyle under large-scale social restrictions. Multivariable logistic regression demonstrated that adults aged 36–45 years had a 3.6 times higher risk of weight changes than young adults aged 25–35 years (<em>p</em> = 0.004, OR = 3.65, 95% CI = 1.51–8.85).</p> <p><strong>CONCLUSIONS</strong> Social restrictions did not affect weight changes and perceptions of a healthy lifestyle in adults during the COVID-19 pandemic in Indonesia. However, older adults might have a higher risk of body weight changes. Controlling body weight is important to prevent further weight gain and the risk of noncommunicable diseases that can aggravate COVID-19.</p>Sorra Milwayani SeptiyanaArif Sabta AjiYhona Paratmanitya
Copyright (c) 2024 Sorra Milwayani Septiyana, Arif Sabta Aji, Yhona Paratmanitya
2024-07-012024-07-01332112810.13181/mji.oa.247222Obesity in urban Indonesia: evidence from the 2007 and 2018 Basic Health Research
https://mji.ui.ac.id/journal/index.php/mji/article/view/7183
<p><strong>BACKGROUND</strong> The prevalence of obesity in urbanizing Indonesia is rising, where the double burden of malnutrition poses a significant challenge. This study aimed to examine the prevalence and increment of obesity-related noncommunicable diseases (NCDs) of diabetes and hypertension.</p> <p><strong>METHODS</strong> Secondary data from the latest 2018 Basic Health Research (<em>RISKESDAS</em>) were used to analyze the obesity rate and its associations with lifestyle, sociodemographics, and certain comorbidities among urban Indonesians. This study included non-pregnant adults aged ≥18 years who lived in the urban area and whose blood pressure and glucose levels were measured in the survey. Results were compared to a similar study using data from 2007.</p> <p><strong>RESULTS</strong> The proportion of obesity among Indonesia’s urban population was more than doubled from 23.0% in 2007 to 50.1% in 2018 for obesity and 28.0% to 57.2% for central obesity. Additionally, females, individuals with higher socioeconomic status, and higher education levels exhibited a higher obesity prevalence.</p> <p><strong>CONCLUSIONS</strong> Urban Indonesia has witnessed a dramatic rise in obesity prevalence. Our findings highlighted the urgent need for policymakers to consider the escalating prevalence of NCDs associated with obesity. Strengthening and concretizing health promotion and prevention policies at the community level are crucial to combat this alarming public health challenge.</p>Ayunina Rizky FerdinaPrisca Petty ArfinesNi Ketut Aryastami
Copyright (c) 2024 Ayunina Rizky Ferdina, Prisca Petty Arfines, Ni Ketut Aryastami
2024-07-242024-07-243321192710.13181/mji.oa.247183Maternal IgG in hemolytic disease of the fetus and newborn-ABO incompatibility
https://mji.ui.ac.id/journal/index.php/mji/article/view/7269
<p><strong>BACKGROUND</strong> Hemolytic disease of the fetus and newborn (HDFN) is a type of anemia in the fetus or newborn, characterized by anemia, jaundice, hyperbilirubinemia, and brain damage. IgG is the only antibody that can cross the placenta. The IgG subtypes have a different ability to destroy red blood cells (RBCs). IgG1 and IgG3 can bind to Fc-phagocyte cell receptors and cause hemolysis, while IgG3 has more ability than IgG1. This study aimed to identify the antibody IgG subtype contributing to clinical manifestation differences in HDFN.</p> <p><strong>METHODS</strong> This study used blood and umbilical cord blood samples from 30 pairs of mother-baby. The samples were grouped into control (not jaundice/normal bilirubin levels) and jaundice/hyperbilirubinemia groups. A self-developed IgG subtype enzyme-linked immunosorbent assay protocol was performed on maternal samples, resulting in optical density. Statistical analysis was performed using SPSS software version 23.</p> <p><strong>RESULTS</strong> Blood type was associated with total bilirubin expression (<em>p</em> = 0.005). IgG1 anti-A, IgG3 anti-A, IgG4 anti-A, IgG1 anti-B, IgG3 anti-B, and IgG4 anti-B significantly affected hyperbilirubinemia in newborns (<em>p</em> = 0.041, 0.013, 0.017, 0.028, 0.001, and 0.007, respectively).</p> <p><strong>CONCLUSIONS</strong> IgG1 and IgG3 were more significant in causing clinical problems. IgG4 suppressed IgG activation, resulting in no destruction of the infant’s RBCs.</p>Heri WibowoSheila NurrahmahRia Syafitri Evi Gantini
Copyright (c) 2024 Heri Wibowo, Sheila Nurrahmah, Ria Syafitri Evi Gantini
2024-07-012024-07-0133270410.13181/mji.oa.247269Effect of selective androgen receptor modulator RAD140 on prostate and testosterone levels in Wistar strain rats with bilateral orchidectomy
https://mji.ui.ac.id/journal/index.php/mji/article/view/7289
<p><strong>BACKGROUND</strong> Selective androgen receptor modulators (SARMs) have been investigated as a potential treatment for hypogonadism, a condition characterized by low testosterone levels in men. The idea is to provide therapeutic benefits similar to traditional testosterone replacement therapy. However, research in this area is still in its early stages, and more extensive studies are needed to establish the efficacy of SARM. This study aimed to determine the impact of SARM RAD140 on testosterone levels, fibromuscular stroma, and prostate mass in rats undergoing bilateral orchidectomy.</p> <p><strong>METHODS</strong> This was an in vivo study using posttest-only control group design in rats (Rattus norvegicus). The positive and negative control groups consisted of rats with and without bilateral orchidectomy, respectively. The treatment groups were rats given SARM RAD140 with and without orchidectomy. Testosterone levels, histopathology, and prostate mass were examined at the end of week 6, and the quantitative data were analyzed using one-way ANOVA.</p> <p><strong>RESULTS</strong> This study found no difference in prostate mass (0.598 [0.05] g <em>vers</em>us 0.590 [0.07] g, <em>p</em> = 0.984), fibromuscular stroma ratio (0.483 [0.094] <em>versus</em> 0.463 [0.057], <em>p</em> = 0.984), and testosterone level (0.006 [0.005] ng/dl <em>versus</em> 0.014 [0.004] ng/dl, <em>p</em> = 0.098) compared to positive control with orchidectomy and SARM RAD140 administration 6 weeks after treatment.</p> <p><strong>CONCLUSIONS</strong> There were no differences in testosterone levels, prostate mass, or the ratio of fibromuscular stroma to epithelium area in rats undergoing bilateral orchidectomy and placebo surgery with the administration of SARM RAD140.</p>Taufiq Nur BudayaPradana NurhadiKenty Wantri AnitaPrasetyo NugrohoFauzan Kurniawan Dhani
Copyright (c) 2024 Taufiq Nur Budaya, Pradana Nurhadi, Kenty Wantri Anita, Prasetyo Nugroho, Fauzan Kurniawan Dhani
2024-07-242024-07-2433275910.13181/mji.oa.247289Flaps or flat: a case report of double free flap survival after a prolonged cardiac arrest
https://mji.ui.ac.id/journal/index.php/mji/article/view/7422
<p>This case addressed patient and free flap survival after cardiac arrest with the contentious use of vasopressors amid concerns about potential vasoconstrictive effects on flap vitality. A 59-year-old male with mucoepidermoid carcinoma underwent post-total maxillectomy and double free flap reconstruction (free fibular flap and anterolateral thigh free flap). Intraoperatively, he experienced cardiac arrest after anastomosis due to hypovolemia or hypoxia, requiring external cardiac massage and vasopressor administration. Despite the initial restoration of circulation, subsequent cardiac arrest ensued, necessitating further resuscitation. Postoperatively, vasopressors were also administered due to hemodynamic instability. Contrary to concerns, both flaps demonstrated sustained vitality, challenging prevailing apprehensions about vasopressor-induced vasoconstriction compromising flap viability. This observation suggests that vasopressors may not significantly threaten flap viability, prompting reconsideration of hesitations and encouraging further investigation. The study advocates for a judicious evaluation of vasopressor administration in free flap procedures, enriching clinical considerations for optimal patient care.</p>Parintosa AtmodiwirjoMohamad Rachadian RamadanMichael DjohanNadira Fildza Amanda
Copyright (c) 2024 Parintosa Atmodiwirjo, Mohamad Rachadian Ramadan, Michael Djohan, Nadira Fildza Amanda
2024-07-242024-07-243321283210.13181/mji.cr.247422Cutting-edge technology application for prostate disease management in Indonesia: implementation of Healthcare 5.0 towards Indonesia’s Golden Vision 2045
https://mji.ui.ac.id/journal/index.php/mji/article/view/7688
<p>[No abstract available]</p>Agus Rizal Ardy Hariandy Hamid
Copyright (c) 2024 Agus Rizal Ardy Hariandy Hamid
2024-07-242024-07-2433263910.13181/mji.com.247688Tackling obesity in Indonesia: current problems and future directions
https://mji.ui.ac.id/journal/index.php/mji/article/view/7691
<p>[No abstract available]</p>Dicky Levenus Tahapary
Copyright (c) 2024 Dicky Levenus Tahapary
2024-07-242024-07-2433261210.13181/mji.ed.247691Front & Back Matter
https://mji.ui.ac.id/journal/index.php/mji/article/view/7703
Medical Journal of Indonesia
Copyright (c) 0
2024-07-242024-07-24332